Assuntos
Coristoma , Neoplasias do Mediastino/diagnóstico , Mediastino , Neoplasias das Paratireoides/diagnóstico , Diagnóstico Diferencial , Seguimentos , Humanos , Masculino , Neoplasias do Mediastino/cirurgia , Pessoa de Meia-Idade , Neoplasias das Paratireoides/cirurgia , Paratireoidectomia , Fatores de Tempo , Tomografia Computadorizada por Raios XRESUMO
The article presents results of examinations and surgical treatment of 300 patients aged from 19 through 72 years with the syndrome of compression of the celiac trunk of the abdominal aorta. Under study were the symptoms and features of the clinical course as well as the possibilities of diagnosis with the help of ultrasonic duplex scanning and aortography. The principal method of treatment of this syndrome is thought to be operative decompression of the celiac trunk resulting in the reestablished hemodynamics in this vessel and in recovery of the greatest part of the patients.
Assuntos
Aorta Abdominal/fisiopatologia , Aorta Abdominal/cirurgia , Estenose da Valva Aórtica/fisiopatologia , Estenose da Valva Aórtica/cirurgia , Artéria Celíaca/fisiopatologia , Artéria Celíaca/cirurgia , Adulto , Idoso , Aorta Abdominal/diagnóstico por imagem , Estenose da Valva Aórtica/diagnóstico , Velocidade do Fluxo Sanguíneo , Artéria Celíaca/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ultrassonografia , Procedimentos Cirúrgicos Vasculares/métodosAssuntos
Neoplasias do Apêndice/complicações , Neoplasias do Apêndice/cirurgia , Tumor Carcinoide/complicações , Tumor Carcinoide/cirurgia , Carcinoma de Células Pequenas , Neoplasias Pulmonares , Idoso , Neoplasias do Apêndice/patologia , Tumor Carcinoide/patologia , Carcinoma de Células Pequenas/complicações , Carcinoma de Células Pequenas/patologia , Carcinoma de Células Pequenas/cirurgia , Humanos , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/cirurgia , MasculinoRESUMO
The effectiveness of different regimens of chemotherapy for advanced pancreatic cancer was compared in 74 cases (1995-1999). 5-fluorouracil (5FU), adriamycin and mitomycin C (FAM) were given to 12 patients, 5FU alone--23, 5FU plus leukovorin--29, and gemcitabine alone--10. Metastases to the liver were detected in 42 (57%) patients. Partial response (40) was registered in: FAM--1 (8%); 5FU--1 (4%); 5FU + leukovorin--3 (10%); gemcitabine--3 (30%). Mean duration (40) was 5.4; 4; 6.1 and 9 months, respectively. Stabilization was recorded in 17 (23%), mean duration--4.4 months; tumor progression--49 (66%). Toxic side-effects of all the regimens were insignificant. Mean survival rates following FAM, 5FU, 5FU + leukovorin were 4.4; 4.2 and 5.6 months, respectively, while that for gemcitabine varied 3-24 months (on average--7.9 months). Survival in patients responsive to chemotherapy was 9.8; remaining patients--4.7 (p (0.05). Chemotherapy for advanced pancreatic carcinoma is a measure of palliation; its use was followed by a 20% increase in survival. Gemcitabine treatment appeared most effective.
